We are live on ! Find out more
CC

Caxton Corporation Portfolio holdings

AUM $4.02M
1-Year Est. Return 256.08%
This Fund
S&P 500
This Quarter Est. Return
-29.91%
1 Year Est. Return
+256.08%
3 Year Est. Return
+777.99%
5 Year Est. Return
+744.68%
10 Year Est. Return
+18,621.85%
AUM
$29.3M
AUM Growth
+$6.98M
Cap. Flow
+$18.5M
Cap. Flow %
63.16%
Top 10 Hldgs %
98.64%
Holding
17
New
3
Increased
7
Reduced
1
Closed
5

Top Buys

1
SBBP
Strongbridge Biopharma plc.
SBBP
+$21.9M
2
AGRX
Agile Therapeutics
AGRX
+$2.45M
3
GARS
Garrison Capital Inc.
GARS
+$342K
4
ACRS icon
Aclaris Therapeutics
ACRS
+$338K
5
TMH
Team Health Holdings Inc
TMH
+$312K

Top Sells

1
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$6.42M
2
CSW
CSW Industrials
CSW
+$364K
3
DOV icon
Dover
DOV
+$237K
4
PFX icon
PhenixFIN
PFX
+$209K
5
SCM icon
Stellus Capital Investment Corp
SCM
+$97.2K

Sector Composition

1 Healthcare 47.28%
2 Financials 6.97%
3 Consumer Discretionary 0.95%
4 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBBP
1
DELISTED
Strongbridge Biopharma plc.
SBBP
$12.9M 44.17%
5,394,994
+5,359,749
+15,207% +$21.9M
AGRX
2
DELISTED
Agile Therapeutics
AGRX
$12.1M 41.3%
1,062
+175
+20% +$2.45M
BRK.B icon
3
Berkshire Hathaway Class B
BRK.B
$1.06T
$1.46M 4.97%
8,945
– –
GARS
4
DELISTED
Garrison Capital Inc.
GARS
$487K 1.66%
52,128
+36,133
+226% +$342K
ICMB icon
5
Investcorp Credit Management BDC
ICMB
$12.3M
$398K 1.36%
43,056
+26,532
+161% +$247K
ACRS icon
6
Aclaris Therapeutics
ACRS
$793M
$359K 1.22%
+13,241
New +$338K
PRTK
7
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$338K 1.15%
21,923
+3,014
+16% +$39.1K
TMH
8
DELISTED
Team Health Holdings Inc
TMH
$328K 1.12%
+7,548
New +$312K
ADNT icon
9
Adient
ADNT
$1.55B
$278K 0.95%
+4,737
New +$250K
ACSF
10
DELISTED
American Capital Senior Floating, Ltd.
ACSF
$213K 0.73%
17,931
+1,592
+10% +$18.2K
CDTX
11
DELISTED
Cidara Therapeutics
CDTX
$212K 0.72%
1,018
+97
+11% +$20.2K
SCM icon
12
Stellus Capital Investment Corp
SCM
$220M
$188K 0.64%
15,593
-8,510
-35% -$97.2K
CSW
13
CSW Industrials
CSW
$4.56B
– –
-11,253
Closed -$364K
DOV icon
14
Dover
DOV
$28.8B
– –
-3,991
Closed -$237K
MDGL icon
15
CALL
Madrigal Pharmaceuticals
MDGL
$12.8B
– –
-2,057
Closed -$26K
MDGL icon
16
Madrigal Pharmaceuticals
MDGL
$12.8B
– –
-506,738
Closed -$6.42M
PFX icon
17
PhenixFIN
PFX
$88.7M
– –
-1,368
Closed -$209K

Similar funds

PCM
Pathway Capital Management Irvine, California $4.3M AUM 62.8% 1-Year Est. Return
EAMS
Eurizon Asset Management Slovakia Bratislava $3.4M AUM
RCP
RPM Capital Partners New York $3.34M AUM 43.17% 1-Year Est. Return
RA
Ritter Alpha New York $4.78M AUM
CGA
Compound Global Advisors Mercer Island, Washington $3.22M AUM 30.08% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
ABA
American Beacon Advisors Irving, Texas $5.08M AUM 20.11% 1-Year Est. Return
UOMF
University of Maryland Foundation Adelphi, Maryland $5.1M AUM 10.69% 1-Year Est. Return

Caxton Corporation's Q4 2016 Portfolio in Review

As of Q4 2016, Caxton Corporation held 17 positions worth $29.3M, up 31% from $22.3M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

Caxton Corporation deployed $18.5M of net new capital in Q4 2016, opening 3 new positions and adding to 7 existing holdings. Its largest new stake was Aclaris Therapeutics: 13,241 shares worth $359K.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Stellus Capital Investment Corp, an estimated $97.2K trimmed.

  • Caxton Corporation's largest Q4 2016 buy was Aclaris Therapeutics: 13,241 shares worth $359K.
  • Caxton Corporation added most to Strongbridge Biopharma plc. in Q4 2016, an estimated $21.9M increase.
  • Caxton Corporation's biggest Q4 2016 reduction was Stellus Capital Investment Corp, cutting an estimated $97.2K.
  • Caxton Corporation fully exited Madrigal Pharmaceuticals in Q4 2016, selling an estimated $6.42M.
  • Caxton Corporation's ten largest holdings make up 99% of its $29.3M portfolio in Q4 2016.
  • Caxton Corporation opened 3 new positions and closed 5 in Q4 2016.
  • Caxton Corporation's portfolio value rose 31% quarter-over-quarter to $29.3M.

Based on Caxton Corporation's 13F filing for Q4 2016, filed 14 Feb 2017.